CHC HEALTHCARE GROUP |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.1 TWD | +2.36% |
|
-0.76% | -14.73% |
| May. 03 | CHC Healthcare Group Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 02 | CHC Healthcare Group Announces Position Adjustment of CIO | CI |
| Sales 2024 * | 3.69B 114M | Sales 2025 * | 4.99B 154M | Capitalization | 8.69B 268M |
|---|---|---|---|---|---|
| Net income 2024 * | 319M 9.85M | Net income 2025 * | 629M 19.41M | EV / Sales 2024 * | 2.36 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.74 x |
| P/E ratio 2024 * |
27.1
x | P/E ratio 2025 * |
13.8
x | Employees | - |
| Yield 2024 * |
3.84% | Yield 2025 * |
-
| Free-Float | 59.89% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.36% | ||
| 1 week | -0.76% | ||
| Current month | -0.76% | ||
| 1 month | -0.19% | ||
| 3 months | -13.88% | ||
| 6 months | -13.60% | ||
| Current year | -14.73% |
1 week
50.20
53.30
1 month
50.2054.40
Current year
50.2062.70
1 year
50.2072.30
3 years
33.0075.70
5 years
27.6575.70
10 years
27.6587.40
| Managers | Title | Age | Since |
|---|---|---|---|
Pei Lin Lee
CEO | Chief Executive Officer | - | 09-11-24 |
Yi Chun Chen
DFI | Director of Finance/CFO | - | 11-01-31 |
Ming Lun Lee
COO | Chief Operating Officer | - | 10-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yung Shun Chuang
BRD | Director/Board Member | - | 14-06-16 |
Pei Lin Lee
CEO | Chief Executive Officer | - | 09-11-24 |
Kuei Tuan Chen
BRD | Director/Board Member | - | 12-01-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 0 M€ | 0.00% | - | |
| 0.00% | 32 M€ | +4.30% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 52.1 | +2.36% | 432,951 |
| 24-06-06 | 50.9 | -0.78% | 775,740 |
| 24-06-05 | 51.3 | -1.72% | 658,209 |
| 24-06-04 | 52.2 | +0.19% | 419,498 |
| 24-06-03 | 52.1 | -0.76% | 300,908 |
End-of-day quote Taiwan S.E., June 06, 2024
More quotes
CHC Healthcare Group is a Taiwan-based investment holding company. The Company primarily involves in the agent distribution of radiation oncology, neurology, medical image and nuclear medical, as well as dental and ophthalmological equipment and instrument. The Company also offers related maintenance and leasing services, components and consumable materials and specialty consulting services. The Company deals with medical instrument with brands as Elekta, PTW, GE, Ashland, Megin, Leica, Hillrom, Sony, Ellex and Wexler, among others. The Company is also involved in the operation of pharmacy.
Calendar
2024-06-11
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
52.1
TWD
Average target price
64
TWD
Spread / Average Target
+22.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.73% | 263M | |
| +11.21% | 198M | |
| +26.13% | 77.74M | |
| +13.61% | 64.96M |
- Stock Market
- Equities
- 4164 Stock
